Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus
Condition: Cutaneous Lichen Planus Intervention: Drug: Baricitinib (LY3009104) Sponsor: Aaron R. Mangold Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2022 Category: Research Source Type: clinical trials